Dawn Dionne-Hamlin

Dawn Dionne-Hamlin currently serves as the Director of Commercial Systems at Intellia Therapeutics, Inc. since September 2025. Previously, Dionne-Hamlin held the position of Director of IT Applications at Mural Oncology from November 2023 to June 2025, where strong relationships with stakeholders were emphasized to support business growth. An extensive career in information technology began at Alkermes, where roles included Associate Director of Commercial and G&A IT, as well as Manager of Commercial IT, spanning from October 2016 to November 2023. Prior experience includes consulting roles at LabAnswer, contributions to Vertex Pharmaceuticals as a Scientific Software Analyst, and early career positions at Millennium Pharmaceuticals, Cereon Genomics, and Whitehead Institute. Dionne-Hamlin holds a B.S. in Biology and Psychology from the University of Maine, earned between 1994 and 1998.